{
    "nctId": "NCT04098640",
    "briefTitle": "Molecular Profiling in Young (<50 Years of Age) Patients With Metastatic Breast Cancer",
    "officialTitle": "Molecular Profiling Using FoundationOne CDx in Young (<50 Years of Age) Patients With Metastatic Breast Cancer (ML41263)",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "Genetic characteristic of young (<50 years of age) Korean patients with metastatic breast cancer.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients between 19 - 50 years of age on the day of signing informed consent.\n* Able to provide written informed consent for voluntary participation in the trial.\n* With metastatic breast cancer\n* Willing to provide biopsies from the primary tumor or lymph nodes at screening to the central laboratory. (with at least 10 unstained slides and 1 H\\&E slide)\n\nExclusion Criteria:\n\n* Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the study.",
    "sex": "FEMALE",
    "minimumAge": "19 Years",
    "stdAges": "ADULT"
}